ARCHIVES

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

This article is from The Cancer Letter archive.

Vol. 18 No. 19 | May 8, 1992

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005

Racial Differences In Survival Increase According To Stage

August 31, 2007

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Seven Seats Open Up On NCAB

January 17, 1986

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000